Hospital
Northern Cochise Community Hospital INC
Northern Cochise Community Hospital INC was paid $8.39M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99284, emergency room visit (serious) — 32% of everything it billed.
33Billing provider infoNORTHERN COCHISE COMMUNITY HOSPITAL INC
WILLCOX, AZ 85643
WILLCOX, AZ 85643
33aNPI1013060367assigned 01/19/2007
33bProvider typeCritical Access Hospital
28Total paid$8.39M
24GClaims123,767
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arizona
Rank by total paid#6 of 15
Median peer was paid$6.92M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,437 | $1.05M | |
| 2019 | 13,669 | $1.13M | |
| 2020 | 8,584 | $1.01M | |
| 2021 | 12,938 | $1.21M | |
| 2022 | 23,877 | $1.43M | |
| 2023 | 27,999 | $1.39M | |
| 2024incomplete | 20,263 | $1.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 5,695 | 5,042 | $2.68M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 3,370 | 2,812 | $1.76M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 5,667 | 5,192 | $1.71M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 10% | 4,228 | 3,590 | $869K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.6% | 429 | 388 | $298K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.4% | 5,927 | 1,725 | $284K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.2% | 4,122 | 3,785 | $181K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 1,082 | 1,015 | $153K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 639 | 613 | $63K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,829 | 1,633 | $60K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 713 | 673 | $46K |
| 80061 | Lipid panel | <1% | 2,065 | 1,939 | $37K |
79 more codes
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 214 | $34K |
| G0378 | Hospital observation service, per hour | <1% | 207 | $33K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 527 | $23K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 436 | $16K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 39 | $13K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,265 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,641 | $9K |
| 83550 | <1% | 445 | $8K | |
| 80053 | Comprehensive metabolic panel | <1% | 9,353 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,999 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,217 | $7K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $7K |
| 72100 | <1% | 56 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,991 | $5K |
| 97161 | <1% | 281 | $4K | |
| 84153 | <1% | 152 | $4K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,294 | $4K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 93 | $4K |
| 73562 | <1% | 56 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,675 | $3K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 2,358 | $3K |
| 87186 | <1% | 508 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,367 | $2K |
| 80306 | <1% | 232 | $2K | |
| 73030 | <1% | 38 | $2K | |
| 84481 | <1% | 118 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,420 | $1K |
| 73610 | <1% | 26 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,050 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,554 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $1K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 39 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 723 | $875.43 |
| 83880 | <1% | 100 | $739.97 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 426 | $604.71 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 971 | $484.97 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 35 | $477.30 |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,068 | $473.33 |
| 73630 | <1% | 13 | $459.17 | |
| 84403 | <1% | 34 | $353.32 | |
| 84484 | <1% | 2,346 | $350.21 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,143 | $333.45 |
| 81001 | <1% | 5,103 | $328.22 | |
| 85610 | <1% | 1,564 | $234.39 | |
| 82607 | <1% | 518 | $229.63 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 247 | $217.12 |
| 82728 | <1% | 193 | $209.05 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 308 | $196.16 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 29 | $190.18 |
| 87430 | <1% | 863 | $151.45 | |
| 80069 | <1% | 71 | $146.09 | |
| 83735 | <1% | 1,852 | $143.64 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 84 | $137.67 |
| 85730 | <1% | 1,066 | $134.23 | |
| 83690 | <1% | 1,750 | $123.37 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 244 | $108.12 |
| 82550 | <1% | 1,018 | $106.66 | |
| 93041 | <1% | 412 | $96.30 | |
| 87280 | <1% | 296 | $90.88 | |
| 87040 | <1% | 91 | $84.42 | |
| 84703 | <1% | 135 | $80.92 | |
| 82043 | <1% | 759 | $61.11 | |
| 83605 | <1% | 941 | $59.77 | |
| 82150 | <1% | 304 | $38.72 | |
| 85379 | <1% | 192 | $37.40 | |
| 82553 | <1% | 217 | $33.78 | |
| 86140 | <1% | 1,329 | $31.47 | |
| 80305 | <1% | 244 | $16.35 | |
| 81025 | <1% | 52 | $14.35 | |
| 87088 | <1% | 379 | $4.86 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 353 | $0.00 |
| 85651 | 0% | 301 | $0.00 | |
| 82746 | 0% | 69 | $0.00 | |
| 94760 | 0% | 30 | $0.00 | |
| 90686 | 0% | 13 | $0.00 | |
| 84439 | 0% | 1,712 | $0.00 | |
| 83540 | 0% | 560 | $0.00 | |
| 84550 | 0% | 29 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 135 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKNOX, ROLAND (CEO)
| Provider | Location | Paid |
|---|---|---|
| MT Graham Regional Medical Center INC | Safford, AZ | $27.72M |
| Sulphur Springs Medical Center | Willcox, AZ | $1.29M |
| Northern Cochise Community Hospital | Willcox, AZ | $79K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.